Education Experience
1999-2002, Ph.D. School of Public Health, Jilin University, Changchun, China.
1991-1994, M.D. Norman Bethune Medical University, Changchun, China.
1986-1991, B.S. Norman Bethune Medical University, Changchun, China.
Working Experience
1994-1996: Assistant in School of preventive medicine, Bethune Medical University
1996-2001: Lecturer in School of preventive medicine, Bethune Medical University
2001-2006: Associate Professor in School of Public Health, Jilin University
2006-2012: Professor in School of Public Health, Jilin University
2004-2008: Post-doctoral in Jilin University Basic Medicine postdoctoral mobile station
2007-2008: Visiting scholar in Karolinska Institute
2012-2018: Vice President in School of Public Health, Jilin University
2018-present: President in School of Public Health, Jilin University
Research Fields
l To study epidemiology and management of risk factor in major chronic diseases.
l To study the influence factors, early warning, and prediction for infectious diseases.
l To study susceptible genes of major chronic diseases macroscopically and microscopically.
Research Projects
2015-2017, Science Technology Department of Jilin Province 100,000RMB
2015-2018, Ministry of science and technology 440,000RMB
2016-2019, National Natural Science Foundation of China(NSFC) 500,000RMB
2018-2021, Ministry of science and technology 397,500RMB
2020-2023, National Natural Science Foundation of China(NSFC) 550,000RMB
Scientific research awards
2014, Science and Technology Award of Jilin Province, second prize
2013, Science and Technology Progress Award of Armed Police Force, second prize
2007, Science and Technology Progress Award of Jilin Province, second prize
2007, Science and Technology Progress Award of Jilin Province, third prize
Talent honorary title
2020, the Sixteenth Batch of Experts with Outstanding Contributions in Jilin Province
2018, Industry Leading Talent Award
2017, Outstanding International Student Instructor Award of Jilin University
2017, Advanced Individual of Teacher Ethics
2015, the Sixth Batch of Experts with Outstanding Contributions in Changchun City
2014, Teaching and Educating Advanced Individuals
2012, The Third-level Candidate of the Third Batch of Top-notch Innovative Talents in Jilin Province
2012, Young and Middle-aged Professional and Technical Personnel with Outstanding Contributions to the Health System of Jilin Province
Professional affiliations
2015.08.20-present Member of the 7th and 8th Standing Committee of cancer epidemiology Committee of China Anti Cancer Association
2018.08.01-present Vice president of the 7th Council of Jilin Preventive Medicine Association
2018.10.01-present Member of the Teaching Steering Committee of public health and preventive medicine in Colleges and universities of the Ministry of Education
2019.05.01-present Standing member of the first committee of public health physicians branch of Chinese Medical Association
2019.07.17-present Member of Epidemiology Branch of Chinese Preventive Medicine Association
2020.10.01-present Member of the fourth decision making Advisory Committee of the CPC Jilin Provincial Committee
Selected Publications
l Qiu S, Li Y, Bai Y, Shi J, Cui H, Gu Y, Ren Y, Zhao Q, Zhang K, Lu M, Wang Y, Li Y, Zhong W, Zhu X, Liu Y, Cheng Y, Qiao Y, Liu Y*. SHANK1 polymorphisms and SNP-SNP interactions among SHANK family: A possible cue for recognition to autism spectrum disorder in infant age. Autism Res. 2019;12(3):375-383.
l Zhao Q, Zhen Q, Li Y, Lv R, Zhang K, Qiao Y, Kou C, Li B, Tao Y, Yu Y, Liu Y, Cheng Y, Liu Y*. Prevalence and risk factors of impaired fasting glucose among adults in northeast China: A Cross-Sectional study. Endocr Pract. 2018;24(7):677-683.
l Gu Y, Shi J, Qiu S, Qiao Y, Zhang X, Cheng Y, Liu Y*. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls. BMC Cancer. 2018;18(1):1060.
l Zhao Q, Zhang K, Li Y, Zhen Q, Shi J, Yu Y, Tao Y, Cheng Y, Liu YW*. Capacity of a body shape index and body roundness index to identify diabetes mellitus in Han Chinese people in Northeast China:a cross-sectional study. Diabetic Medicine. 2018;35(11):1580-1587.
l Shi JK, Liu YW, Liu YK, Li Y, Qiu S, Bai Y, Gu YL, Luo JJ, Cui HR, Li Y, Zhao Q, Zhang KX, ChengY. Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controls. Gene. 2018; 675:197-207.
l Shi J, Bai Y, Qiu S, Li Y, Kou C, Tao Y, Zhen Q, Gu Y, Yu Y, Zhang K, Cheng Y, Liu Y*. Classified status of smoking and quitting has different associations with dyslipidemia in residents in northeast China. Clin Chim Acta. 2018;486(1):209-213.
l Kanu J S, Qiu S, Cheng Y, Li R, Kou CG, Gu YL, Bai Y, Shi JK, Li Y, Liu YK, Yu YQ, Liu YW*. Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ, and cardiovascular disease: a meta-analysis. Lipids in Health & Disease. 2018; 17(1):126.
l Bai Y, Qiu S, Li Y, Li Y, Zhong WJ, Shi MJ, Zhu XJ, Jiang HY, Yu YQ, Cheng Y*, Liu YW*. Genetic association between SHANK2 polymorphisms and susceptibility to autism spectrum disorder. IUBMB Life. 2018;70(8):763-76.
l Qiu S, Li Y, Li Y, Zhong WJ, Shi MJ, Zhao Q, Zhang KX, Wang YH, Lu MH, Zhu XJ, Jiang Hy, Yu YQ, Cheng Y*, Liu YW*. Association between SHANK3 polymorphisms and susceptibility to autism spectrum disorder. Gene. 2018;651:100-105.
l Zhang K, Zhao Q, Li Y, Zhen Q, Yu YQ, Tao YC, Cheng Y, Liu YW*. Feasibility of anthropometric indices to identify dyslipidemia among adults in Jilin Province: a cross-sectional study. Lipids in Health and Disease. 2018; 17(1):16.
l Shicheng Liu, Shuang Qiu, Yuping Lu, Joseph Sam Kanu, Ri Li, Ye Bai, Xiaojuan Zhu, Jie Lei, Naijun Xu, Yaqin Yu, Yawen Liu*, Huiyi Jiang*. The rs251684 Variant of PLA2G4C Is Associated with Autism Spectrum Disorder in the Northeast Han Chinese Population. Genetic testing and molecular biomarkers, 2016;20(12):747-752.
l He Huan, Zhen Qing, Li Yong, Kou Changgui, Tao Yuchun, Wangchang, Joseph Sam Kanu, Lu Yuping, Yu Mingxi, Zhang Huiping, Yu Yaqin, Li Bo*, Liu Yawen*. Prevalence of High Non-high-density Lipoprotein Cholesterol and Associated Risk Factors in Patients with Diabetes Mellitus in Jilin Province, China: A Cross-sectional Study. Biomed Environ Sci. 2016;29(7):534-538.
l Yu, MX; Liu, YW; Li, Y; Zhang, HP; Lu, YP; Kanui, JS; Qiao, YC; Tang, Y; Zhen, Q; Cheng, Y. Endothelial lipase gene polymorphisms are associated with serum HDL-C levels but not coronary heart disease. International Journal Of Clinical And Experimental Pathology.2016;9(2): 2181-2191.
l Joseph Sam Kanu, Yulu Gu, Sun Zhi, Mingxi Yu, Yuping Lu, Yetong Cong, Yunkai Liu, Yong Li, Yaqin Yu, Yi Cheng* and Yawen Liu*. Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case control study. Lipids Health Dis. 2016;15(1):6.
l Li R, Li WC, Lun ZJ, Zhang HP, Sun Z, Kanu JS, Qiu S, Cheng Y, Liu YW*. Prevalence of metabolic syndrome in mainland china: a meta analysis of published studies. Bmc Public Health. 2016;16(1):296-305.
l Xin Zhang, Yulu Gu, Xiaoli Liu, Yaqin Yu, Jieping Shi, Qiong Yu, Hui Sun, Joseph Sam Kanu, Siyan Zhan*, and Yawen Liu*. Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer. Int J Endocrinol. 2015:802562.
l Yuping Lu, Yawen Liu, Yong Li, Huiping Zhang, Mingxi Yu, Joseph Sam Kanu, Yichun Qiao, Yuan Tang, Qing Zhen, Yi Cheng*. Association of ATP-binding cassette transporter A1 gene polymorphisms with plasma lipid variability and coronary heart disease risk. Int J Clin Exp Pathol. 2015;8(10):13441-9.
l Wang F, Liu Y, Cong Y, Li P, Li Y, Yan Z, Tang Y, Cheng Y, Zheng Y. Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: a marker of atherosclerosis in patients with normal cholesterol levels. Clin Chim Acta. 2015; 438:370-375.
